☆ 4.7 Editorial Material

Zipalertinib in EGFR Exon 20-Mutant Non-Small-Cell Lung Cancer: Drug Development in a Rare but Crowded Setting

JOURNAL OF CLINICAL ONCOLOGY (2023)

Journal

JOURNAL OF CLINICAL ONCOLOGY

Volume 41, Issue 26, Pages 4200-2023

Publisher

LIPPINCOTT WILLIAMS & WILKINS

DOI: 10.1200/JCO.23.00958

Keywords

-

Categories

Oncology

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper

Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7

Not enough ratings

Secondary Ratings

Novelty

-

Significance

-

Scientific rigor

-

Rate this paper

Recommended

No Data Available

No Data Available

No Data Available

© Peeref 2019-2024. All rights reserved.